Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cureus|June 6, 2022
Herb-Induced Liver Injury: A Report on Two Australian CasesVarun Peri, Catherine Yu, Karl Vaz, et al.
Seminars in Liver Disease|July 30, 2021
Artificial Intelligence in Hepatology: A Narrative ReviewKarl Vaz, Thomas Goodwin, William Kemp, et al.
Digestive Diseases and Sciences|July 7, 2021
Determinants of Short- and Long-Term Outcomes of an Australian Cohort of Patients Admitted with Alcoholic HepatitisKarl Vaz, Robert Little, Ammar Majeed, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 29, 2024
Long-Term Continuous Terlipressin Infusion Improves Cardiac Reserve in Patients With Decompensated CirrhosisRyma Terbah, Anoop N Koshy, Avik Majumdar, et al.
Journal of Medical Case Reports|March 10, 2019
Gastric adenocarcinoma causing biliary obstruction without ductal dilatation: a case reportKarl Vaz, Raphael P Luber, Catriona McLean, et al.
The Medical Journal of Australia|May 10, 2026
Fatty Liver Disease in Australia: A Narrative Review on the Epidemiology, Natural History, Prognostication and Management in People With Metabolic DysfunctionKarl Vaz, Daniel Clayton-Chubb, William W Kemp, et al.
Hepatology International|August 9, 2023
Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomesKarl Vaz, Daniel Clayton-Chubb, Ammar Majeed, et al.
Internal Medicine Journal|May 21, 2026
Healthcare costs of managing MAFLD are mostly driven by hospitalisation and advanced fibrosis: cost metabolic (dysfunction)-associated fatty liver disease analysis from a tertiary-care, multi-disciplinary MAFLD clinicNatalie Ngu, Karl Vaz, Tobie Abrahams, et al.
Internal Medicine Journal|September 20, 2018
Inflammatory bowel disease incidence, prevalence and 12-month initial disease course in Tasmania, AustraliaRajesh Bhatia, Sern Wei Yeoh, Karl Vaz, et al.
Internal Medicine Journal|September 17, 2022
Rate of early hospital readmission amongst cirrhotic patients is high in Australia: experience from a single liver transplant centreKarl Vaz, Katrina Tan, Melissa Chew, et al.
Pageof 3